Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies

BACKGROUND: Concerns have been raised that treatment of COPD with inhaled corticosteroids may increase pneumonia risk. Responding to a request from the European Medicines Agency Pharmacovigilance Risk Assessment Committee, a pooled analysis of interventional studies compared pneumonia risk with inha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollis, Sally, Jorup, Carin, Lythgoe, Dan, Martensson, Gunnar, Regnell, Pontus, Eckerwall, Göran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389656/
https://www.ncbi.nlm.nih.gov/pubmed/28435240
http://dx.doi.org/10.2147/COPD.S128358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389656/
https://www.ncbi.nlm.nih.gov/pubmed/28435240
http://dx.doi.org/10.2147/COPD.S128358

Ejemplares similares